Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-016233
Filing Date
2017-06-13
Accepted
2017-06-13 16:35:38
Documents
1
Period of Report
2017-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4396
  Complete submission text file 0000899243-17-016233.txt   5771
Mailing Address CRITICAL THERAPEUTICS INC 60 WESTVIEW STREET LEXINGTON MA 02421
Business Address
George Jean (Reporting) CIK: 0001291804 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36644 | Film No.: 17909232

Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Issuer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations